Trasylol Lawsuits, Litigation & Lawyers

Bayer Pharmaceuticals, the manufacturer of the recently banned anti-bleeding drug, Trasylol, is facing an avalanche of lawsuits in the U.S. The FDA (Food and Drug Administration) ordered sales of the drug suspended in the U.S. when a Canadian government study was stopped for ethical reasons, because Trasylol was causing too many deaths. In May of 2008 Bayer bowed to the inevitable and began permanently removing the drug from the U.S. market.

A month before the final withdrawal began, Bayer’s CEO admitted that 78 lawsuits had been filed against it in the U.S., but none yet in other countries. This litigation may have been stimulated by a CBS 60 Minutes program aired on February, 17, 2008. The program revealed that Bayer had known about an additional study showing the dangers of Trasylol in 2006, but withheld the information from the FDA. The Harvard researcher hired to do the research blew the whistle on the company and released the information. Even then, the FDA did not take action to ban the drug. The researcher in a major 2006 Trasylol study estimates that 22,000 people died from Trasylol use between 2006 and November 2007 because the FDA failed to take action.

The program also presented the case of a man who underwent low risk surgery for heart valve replacement, but because of Trasylol suffered 2 heart attacks and kidney failure. He went through a series of very painful procedures before dying a few months later. His family has sued Bayer.

Because of the large number of people who died from Trasylol use or who have required long-term dialysis or kidney implant, and because of the clear evidence that Bayer withheld information from the FDA, commentators expect many Trasylol lawsuits to be filed.

Check out the following articles for more information about Trasylol, filing a Trasylol lawsuit and finding a Trasylol attorney.